Respecting that, blocking NF-κB by specific inhibitor had no significant impact on TRAIL-induced apoptosis in HCC cells, which could indicate that NF-κB activities may not contribute to the TRAIL resistance of HCC cells (91). The gene discussed is NFKB1; the disease is hepatocellular carcinoma.